Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer

por Hillerdal, Victoria, Essand, Magnus
Publicado 2015

Systemic treatment with CAR-engineered T cells against PSCA delays subcutaneous tumor growth and prolongs survival of mice

por Hillerdal, Victoria, Ramachandran, Mohanraj, Leja, Justyna, Essand, Magnus
Publicado 2014

Avidity characterization of genetically engineered T-cells with novel and established approaches

por Hillerdal, Victoria, Boura, Vanessa F., Björkelund, Hanna, Andersson, Karl, Essand, Magnus
Publicado 2016

Allogeneic lymphocyte-licensed DCs expand T cells with improved antitumor activity and resistance to oxidative stress and immunosuppressive factors

por Jin, Chuan, Yu, Di, Hillerdal, Victoria, Wallgren, AnnaCarin, Karlsson-Parra, Alex, Essand, Magnus
Publicado 2014